BRPI0413882A - forma de dosagem farmacêutica sólida - Google Patents
forma de dosagem farmacêutica sólidaInfo
- Publication number
- BRPI0413882A BRPI0413882A BRPI0413882-1A BRPI0413882A BRPI0413882A BR PI0413882 A BRPI0413882 A BR PI0413882A BR PI0413882 A BRPI0413882 A BR PI0413882A BR PI0413882 A BRPI0413882 A BR PI0413882A
- Authority
- BR
- Brazil
- Prior art keywords
- dosage form
- pharmaceutical dosage
- solid pharmaceutical
- pharmaceutically acceptable
- water soluble
- Prior art date
Links
Landscapes
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US50617803A | 2003-08-28 | 2003-08-28 | |
PCT/US2004/027401 WO2005039551A2 (en) | 2003-08-28 | 2004-08-23 | Solid pharmaceutical dosage form comprising an hiv protease inhibitor solid dispersion |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0413882A true BRPI0413882A (pt) | 2006-10-24 |
Family
ID=37137320
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0413882-1A BRPI0413882A (pt) | 2003-08-28 | 2004-08-23 | forma de dosagem farmacêutica sólida |
Country Status (1)
Country | Link |
---|---|
BR (1) | BRPI0413882A (pt) |
-
2004
- 2004-08-23 BR BRPI0413882-1A patent/BRPI0413882A/pt not_active Application Discontinuation
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RS59969B1 (sr) | Čvrsti farmaceutski dozni oblik | |
BRPI0619868A8 (pt) | Dispersão sólida compreendendo um ingrediente ativo tendo um ponto de fusão baixo e comprimido para administração oral compreendendo o mesmo | |
UA89220C2 (ru) | Способ лечения вич/спида путем приема без пищи или в условиях голодания твердого фармацевтического дозированного состава ингибитора вич-протеазы | |
NO20025601D0 (no) | Arylmetylaminderivater for anvendelse som tryptaseinhibitorer | |
BR0307524A (pt) | Composição farmacêutica para inibidores de protease viral de hepatite c | |
AR041089A1 (es) | Procedimiento y composiciones farmaceutiicas para tratar aterosclerosis, dislipidemias y afecciones relacionadas | |
MX2010005175A (es) | Comprimido dispersable oral. | |
ATE516016T1 (de) | Selbstemulgierende formulierungen von cetp- hemmern | |
SV2003000633A (es) | Nuevos tiadiazoles y oxadiazoles y su uso como inhibidores de fosfodiesterasa-7 | |
SG147450A1 (en) | Sustained release pharmaceutical compositions comprising aplindore and derivatives thereof | |
BR0209283A (pt) | Método para a fabricação de uma composição farmacêutica de baixa dosagem tendo distribuição e potência de droga uniforme | |
BRPI0415053B8 (pt) | inibidor de glicoproteína-p, método para preparar o mesmo e composição farmacêutica que compreende o mesmo | |
BR0209155A (pt) | Tablete farmacêutico tendo um teor de api elevado | |
BRPI0413882A (pt) | forma de dosagem farmacêutica sólida | |
DE60121142D1 (de) | Zusammensetzung die paracetamol und niflumic säure enthält | |
CL2004001071A1 (es) | Composicion farmaceutica que comprende modafinilo, un farmaco antineoplasico y un vehiculo farmaceuticamente aceptable. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B15K | Others concerning applications: alteration of classification |
Free format text: PARA: INT. CL. A61K 9/14, 9/20, 31/425; A61P 31/14 Ipc: A61K 9/14 (2011.01), A61K 9/20 (2011.01), A61K 31/ |
|
B65X | Notification of requirement for priority examination of patent application | ||
B65Y | Grant of priority examination of the patent application (request complies with dec. 132/06 of 20061117) | ||
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B25A | Requested transfer of rights approved |
Owner name: ABBVIE INC. (US) |
|
B15W | Others matters related to applications: legal action concerning application |
Free format text: INPI-52400.115597/2014-91 ORIGEM: JUIZO DA 031A VARA FEDERAL DO RIO DE JANEIRO PROCESSO NO 0126330-82.2014.4.02.5101 ACAO ORDINARIA COM PEDIDO DE TUTELA ANTECIPADA AUTOR: ABBVIE INC REU: AGENCIA NACIONAL DE VIGILANCIA SANITARIA - ANVISA. |
|
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: INDEFIRO O PEDIDO DE ACORDO COM OS ARTIGOS 8O E 13 DA LPI. |
|
B12B | Appeal against refusal [chapter 12.2 patent gazette] | ||
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
B10A | Cessation: cessation confirmed |